BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32189188)

  • 1. Distant metastases from pathologically proven benign follicular nodules of the thyroid: clinicopathological features and predictors of long-term survival.
    Qiu ZL; Shen CT; Sun ZK; Tang J; Song HJ; Zhang GQ; Luo QY
    Endocrine; 2020 Jul; 69(1):113-125. PubMed ID: 32189188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.
    Qiu ZL; Shen CT; Sun ZK; Song HJ; Xi C; Zhang GQ; Wang Y; Luo QY
    Front Endocrinol (Lausanne); 2020; 11():588024. PubMed ID: 33716950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation profiles of follicular thyroid tumors by targeted sequencing.
    Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
    Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
    Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Thyroid; 2012 Aug; 22(8):798-804. PubMed ID: 22853727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
    Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
    Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
    Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
    Qiu ZL; Shen CT; Luo QY
    Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
    Livhits MJ; Pasternak JD; Xiong M; Li N; Gosnell JE; Yeh MW; Chiu HK
    Endocr Pract; 2016 Nov; 22(11):1259-1266. PubMed ID: 27482611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
    Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
    Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP.
    Nishigami K; Liu Z; Taniguchi E; Koike E; Ozaki T; Mori I; Kakudo K
    Endocr J; 2012; 59(6):483-7. PubMed ID: 22484994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.
    Liu Z; Zhou G; Nakamura M; Koike E; Li Y; Ozaki T; Mori I; Taniguchi E; Kakudo K
    Cancer Sci; 2011 Jan; 102(1):288-94. PubMed ID: 21070478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
    Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
    Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.
    Kakudo K
    Gland Surg; 2018 Aug; 7(Suppl 1):S8-S18. PubMed ID: 30175059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of follicular tumor of uncertain malignant potential of the thyroid: real-world data.
    Ito Y; Hirokawa M; Hayashi T; Kihara M; Onoda N; Miya A; Miyauchi A
    Endocr J; 2022 Jul; 69(7):757-761. PubMed ID: 35082189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?
    Robinson A; Schneider D; Sippel R; Chen H
    J Surg Res; 2017 Jan; 207():235-240. PubMed ID: 27979483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.